Unknown

Dataset Information

0

A Sensitive, Rapid, and Portable CasRx-based Diagnostic Assay for SARS-CoV-2.


ABSTRACT: Since its first emergence from China in late 2019, the SARS-CoV-2 virus has spread globally despite unprecedented containment efforts, resulting in a catastrophic worldwide pandemic. Successful identification and isolation of infected individuals can drastically curtail virus spread and limit outbreaks. However, during the early stages of global transmission, point-of-care diagnostics were largely unavailable and continue to remain difficult to procure, greatly inhibiting public health efforts to mitigate spread. Furthermore, the most prevalent testing kits rely on reagent- and time-intensive protocols to detect viral RNA, preventing rapid and cost-effective diagnosis. Therefore the development of an extensive toolkit for point-of-care diagnostics that is expeditiously adaptable to new emerging pathogens is of critical public health importance. Recently, a number of novel CRISPR-based diagnostics have been developed to detect COVID-19. Herein, we outline the development of a CRISPR-based nucleic acid molecular diagnostic utilizing a Cas13d ribonuclease derived from Ruminococcus flavefaciens (CasRx) to detect SARS-CoV-2, an approach we term SENSR (Sensitive Enzymatic Nucleic-acid Sequence Reporter). We demonstrate SENSR robustly detects SARS-CoV-2 sequences in both synthetic and patient-derived samples by lateral flow and fluorescence, thus expanding the available point-of-care diagnostics to combat current and future pandemics.

SUBMITTER: Brogan DJ 

PROVIDER: S-EPMC7587836 | biostudies-literature | 2020 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications


Since its first emergence from China in late 2019, the SARS-CoV-2 virus has spread globally despite unprecedented containment efforts, resulting in a catastrophic worldwide pandemic. Successful identification and isolation of infected individuals can drastically curtail virus spread and limit outbreaks. However, during the early stages of global transmission, point-of-care diagnostics were largely unavailable and continue to remain difficult to procure, greatly inhibiting public health efforts t  ...[more]

Similar Datasets

| S-EPMC8577378 | biostudies-literature
| S-EPMC9538558 | biostudies-literature
| S-EPMC9024885 | biostudies-literature
2022-06-03 | E-MTAB-11261 | biostudies-arrayexpress
| S-EPMC10276524 | biostudies-literature
| S-EPMC7927608 | biostudies-literature
| S-EPMC8513858 | biostudies-literature
| S-EPMC8751644 | biostudies-literature
| S-EPMC10377351 | biostudies-literature
| S-EPMC9428490 | biostudies-literature